Dupont Capital Management Corp Purchases 6,820 Shares of Danaher Corporation $DHR

Key Points

• Dupont Capital Management Corp has increased its stake in Danaher Corporation by 18.9%, acquiring an additional 6,820 shares during the second quarter, bringing its total holdings to 42,942 shares valued at $8.48 million.
• Danaher recently announced a quarterly dividend of $0.32 per share, which will be paid to investors on October 31st, with a dividend yield of 0.6%.
• The stock of Danaher Corporation has seen a 0.5% decrease recently and analysts have a consensus target price of $245.00, with the majority rating it as a "Moderate Buy."

Dupont Capital Management Corp increased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 18.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 42,942 shares of the conglomerate's stock after acquiring an additional 6,820 shares during the period. Dupont Capital Management Corp's holdings in Danaher were worth $8,483,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its position in Danaher by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 59,981,088 shares of the conglomerate's stock worth $12,296,123,000 after acquiring an additional 230,966 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in Danaher by 3.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 19,592,211 shares of the conglomerate's stock worth $4,016,404,000 after acquiring an additional 612,154 shares during the last quarter. Bank of New York Mellon Corp grew its position in Danaher by 2.3% during the 1st quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate's stock worth $1,800,614,000 after acquiring an additional 194,466 shares during the last quarter. Invesco Ltd. grew its position in Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after acquiring an additional 1,450,703 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Danaher by 4.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,230,087 shares of the conglomerate's stock worth $867,168,000 after acquiring an additional 163,332 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the company's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.20% of the stock is currently owned by insiders.

Danaher Stock Down 0.5%

Shares of Danaher stock opened at $208.06 on Tuesday. Danaher Corporation has a one year low of $171.00 and a one year high of $274.21. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The stock's 50-day moving average is $201.76 and its 200 day moving average is $197.42. The firm has a market cap of $148.98 billion, a price-to-earnings ratio of 44.27, a PEG ratio of 2.98 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter in the prior year, the company earned $1.72 EPS. The firm's revenue for the quarter was up 3.4% compared to the same quarter last year. Equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher's dividend payout ratio is presently 27.23%.

Wall Street Analyst Weigh In

A number of research firms have commented on DHR. Rothschild Redb lowered Danaher from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, October 8th. Wells Fargo & Company reduced their price target on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Redburn Partners set a $220.00 price target on Danaher in a research report on Wednesday, October 8th. Evercore ISI upped their price target on Danaher from $226.00 to $245.00 and gave the company an "outperform" rating in a research report on Tuesday, October 7th. Finally, Barclays reiterated an "overweight" rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $245.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.